Holen Sie sich die Stockscreener-App
0.893
9.31%
-0.0917
Vorhandelsmarkt:
.89
-0.003
-0.34%
Schlusskurs vom Vortag:
$0.9847
Offen:
$0.98
24-Stunden-Volumen:
3.27M
Relative Volume:
8.30
Marktkapitalisierung:
$45.87M
Einnahmen:
$107.88M
Nettoeinkommen (Verlust:
$-33.52M
KGV:
-1.3312
EPS:
-0.6708
Netto-Cashflow:
$-11.94M
1W Leistung:
-55.35%
1M Leistung:
-61.34%
6M Leistung:
-75.47%
1J Leistung:
-53.00%
1-Tages-Spanne:
$0.68
$0.98
1-Wochen-Bereich:
$0.68
$2.11
52-Wochen-Spanne:
$0.68
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare MDXH vs TMO, DHR, IDXX, WAT, A
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
0.893 | 50.58M | 107.88M | -33.52M | -11.94M | -0.6708 |
TMO
Thermo Fisher Scientific Inc
|
438.34 | 166.56B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
161.91 | 116.46B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
528.79 | 42.03B | 4.45B | 1.10B | 1.06B | 13.59 |
WAT
Waters Corp
|
329.22 | 32.72B | 3.77B | 449.25M | 240.68M | 7.8556 |
A
Agilent Technologies Inc
|
111.70 | 32.01B | 7.07B | 1.29B | 993.00M | 4.5355 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
MDxHealth SA stock (US55278X1072): cancer diagnostics specialist back in focus after capital raise - AD HOC NEWS
MDxHealth SA (MDXH) Q1 2026 Earnings Miss: EPS $-0.19 vs $-0.15 ExpectedStock Analysis Community - newser.com
MDxHealth Exits UTI Business Amid Medicare Reimbursement Dispute - HarianBasis.co
MDxHealth S.A. (NASDAQ:MDXH) Q1 2026 Earnings Call Transcript - Insider Monkey
MDxHealth (MDXH) Q1 Loss Near US$8.9 Million Reinforces Bearish Profitability Concerns - simplywall.st
MDXH Sets New Revenue Forecast Excluding Resolve, Anticipates St - GuruFocus
MDXH Maintained by Lake Street -- Price Target Lowered to $5.00 - GuruFocus
Mdxhealth Earnings Call: Prostate Pivot Amid Pressure - TipRanks
MDXH Maintained by TD Cowen -- Price Target Lowered to $1.50 - GuruFocus
MDXH Faces Challenges Amid Strategic Revisions and Medicare Disp - GuruFocus
MDxHealth SA Stock 12‑Month Price Target Cut to $3.9, Implies 100% Upside - TradingView
MDxHealth to exit the Resolve mdx business - TipRanks
MDxHealth price target lowered to $4 from $7 at BTIG - TipRanks
MDxHealth SA Stock 12‑Month Price Target Cut to $4.7, Implies 141% Upside - TradingView
TD Cowen cuts MDxHealth stock price target on Medicare dispute By Investing.com - Investing.com Australia
TD Cowen cuts MDxHealth stock price target on Medicare dispute - Investing.com
MDXH Maintained by BTIG -- Price Target Lowered to $4.00 - GuruFocus
Dow Jumps Over 250 Points; US Retail Sales Increase In April - Benzinga
MDxHealth SA stock (US55278X1072): Strong Q1 results amid strategic shift - AD HOC NEWS
MDxHealth SA Stock 12‑Month Price Target Cut to $5.7, Implies 192% Upside - TradingView
MDxHealth SA Stock 12‑Month Price Target Cut to $6.8, Implies 249% Upside - TradingView
MDxHealth SA (MDXH) Q1 2026 Earnings Call Highlights: Revenue Su - GuruFocus
MDxHealth Q1 Earnings Call Highlights - inkl
Mdxhealth exits Texas Resolve lab after $10.4M Medicare recoupment - Stock Titan
MDXH Reports Strong Q1 Results Amid Strategic Business Changes - GuruFocus
MDXH: Exited UTI business, focusing on AI-driven prostate cancer diagnostics with 20–26% growth outlook - TradingView
MDXH: Exited UTI business, core cancer revenue up 11%, 2026 guidance set at $110–$115 million - TradingView
Earnings call transcript: MDxHealth Q1 2026 results miss forecasts, stock steady - Investing.com
Mdxhealth Exits Resolve Business, Refocuses on Prostate Cancer as Q1 2026 Revenue Rises 13% - TipRanks
MDxHealth Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Mdxhealth reports Q1-2026 results - marketscreener.com
MDxHealth (NASDAQ: MDXH) posts Q1 2026 growth and issues new 2026 guidance - Stock Titan
MDxHealth reports Q1 EPS (17c) vs. (19c) last year - TipRanks
MSN Money - MSN
MDxHealth SA expected to post a loss of 15 cents a shareEarnings Preview - TradingView
Number of shareholders of MDxHealth SA – NASDAQ:MDXH - TradingView
MDXH SEC FilingsMdxhealth Sa 10-K, 10-Q, 8-K Forms - Stock Titan
Press Release: Mdxhealth to Release First Quarter 2026 Financial Results on May 13 - Moomoo
Mdxhealth to Release First Quarter 2026 Financial Results on May 13 - The Manila Times
Mdxhealth schedules May 13 webcast and Q&A for Q1 results - Stock Titan
MDxHealth Sets May 28, 2026 Shareholders’ Meetings to Approve 2025 Accounts and Governance Moves - TipRanks
MDxHealth (NASDAQ: MDXH) seeks approval for 2026 warrants, option plan and authorized capital - Stock Titan
MDxHealth SA (MDXH) Stock: Risk Factors Evaluation (Trend Weakens) 2026-04-27Support Bounce - newser.com
Press Release: Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results - Moomoo
MDxHealth SA (NASDAQ:MDXH) Short Interest Down 73.9% in April - MarketBeat
MDXH MDxHealth SA Q4 2025 earnings miss estimates, 19.8% YoY revenue growth fails to stop 5.19% share drop.Community Sell Signals - Cổng thông tin điện tử tỉnh Tây Ninh
MDXH (MDxHealth SA Ordinary Shares) Q4 2025 revenue grows 19.8 percent year over year, shares rise 1.76 percent despite EPS miss.Dividend Safety - UBND thành phố Hải Phòng
MDxHealth SA (MDXH) Stock: Why It Could Volatile (Recovers) 2026-04-20Company Analysis - Cổng thông tin điện tử tỉnh Lào Cai
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):